EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Local Corticosteroid Injection Versus Open Surgical Release in De Quervain Tenosynovitis: A Prospective Non-Randomized Comparative Study

Saad Riaz, Osama Ijaz, Abdur Rehman, Talha Farooq, Ali Asad Ullah

Journal of Rawalpindi Medical College · 2026

DOI: 10.37939/jrmc.3240 ↗
AbstractBibliografische Angaben

Abstract

Objective: De Quervain tenosynovitis is a frequent cause of radial-sided wrist pain in clinical practice and is a stenosing tendinopathy involving the first dorsal extensor compartment of the wrist. Corticosteroid injection and surgical release are widely used for its treatment; however, there is a lack of comparative evidence on the effectiveness of these treatments in a real clinical setting. Methods: In this prospective, non-randomised, single-centre comparative study (ClinicalTrials.gov: NCT07683429), 100 patients with clinically diagnosed De Quervain tenosynovitis who failed to respond to initial conservative treatment were enrolled. Forty-nine patients were allocated to corticosteroid injection (CSI), and 51 to open surgical release (OSR) treatment, based on the investigators' clinical judgment and patient choice. The Visual Analogue Scale (VAS, 0-10) was used to measure pain severity at baseline, 1 month, and 6 months after the intervention. Independent samples t-tests were used to compare the differences between groups, and a linear mixed-effects model was used to model pain trajectories over time. The normality of continuous variables was checked before parametric analysis using the Shapiro-Wilk test. A trained assessor blinded to the treatment allocation performed the VAS assessments at follow-up. Results: Most of the cohort (72%) were women, and the mean age was 36.7 ± 8.0 years. There were no significant differences in age or sex between the two groups; however, the VAS scores were slightly higher in the surgical group (8.71 ± 1.06) than in the CSI group (8.27 ± 0.97; p = 0.033) at baseline. The surgical release group had significantly lower pain scores at 1 month (1.49 ± 0.78) than the CSI group (3.22 ± 1.07; p < 0.001). This difference persisted and widened at six months (surgical: 0.59 ± 0.57 versus CSI: 2.88 ± 1.18; p < 0.001). There was a significant group × time interaction (p < 0.001) for the linear mixed-effects modelling for pain scores over follow-up, indicating that the surgical release group had greater and more lasting reductions in pain. No significant complications were observed in either group. Conclusion: Corticosteroid injection and open surgical release are effective treatments for De Quervain tenosynovitis. Surgical release was more effective and long-lasting in relieving pain, particularly in cases of chronic or intractable pain. However, corticosteroid injection remains a minimally invasive first-line treatment. Treatment decisions should be based on the severity of symptoms, patient preference, and available resources. Keywords: De Quervain tenosynovitis; corticosteroid injection; surgical release; visual analog scale; prospective non-randomized comparative study.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →